Cyprotex performing ahead of expectations

CHESHIRE biotech company Cyprotex says it financial performance for the first five months of the year is ahead of expectations, driven by strong growth in the UK and in the face of “challenges” in its US operations.

“The board expects that its full year revenues and profits will exceed current market expectations,” a company statement said.

The AIM-listed company has sites in Macclesfield, Watertown in Massachusetts and Kalamazoo, Michigan in the US.

In April Cyrpotex reporte... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...